Ford G D
Fed Proc. 1976 May 1;35(6):1298-301.
Vascular smooth muscle relies on two general sources of activator calcium, one the extracellular fluid and the other intracellular sites in the coupling between stimulation at the external membrane and tension development. Electron microscopic studies have demonstrated at least two subcellular elements, mitochondria and sarcoplasmic reticulum, that may participate in the release and/or sequestration of this activator calcium. In order to obtain quantitative answers to questions concerning the rates of calcium transport by these subcellular elements attempts to use differential centrifugation to obtain subcellular fractions from whole muscle homogenate have been reported. Mitochondrial enriched preparations have received little quantitative study as yet, although they possess active calcium uptake mechanisms. Nonmitochondrial preparations having active calcium uptake mechanisms have been found in a variety of smooth muscles. The method of preparation and properties of these nonmitochondrial preparations show a great deal of variation, indicating they are probably a heterogeneous mixture of sarcoplasmic reticulum and plasma membrane. Some preliminary experiments on the effects of vasoactive agents and cyclic AMP on the calcium transport by these nonmitochondrial preparations have yielded conflicting results. Resolution of these problems awaits clear identification of the calcium transport mechanisms with their appropriate subcellular structure.
血管平滑肌依赖于两种主要的激活钙来源,一种是细胞外液,另一种是在外膜刺激与张力产生之间的偶联过程中的细胞内位点。电子显微镜研究表明,至少有两种亚细胞成分,即线粒体和肌浆网,可能参与这种激活钙的释放和/或螯合。为了定量回答有关这些亚细胞成分钙转运速率的问题,已有报道尝试用差速离心法从全肌肉匀浆中获得亚细胞组分。富含线粒体的制剂尚未得到太多定量研究,尽管它们具有活跃的钙摄取机制。在多种平滑肌中都发现了具有活跃钙摄取机制的非线粒体制剂。这些非线粒体制剂的制备方法和特性差异很大,表明它们可能是肌浆网和质膜的异质混合物。关于血管活性药物和环磷酸腺苷对这些非线粒体制剂钙转运的影响的一些初步实验得出了相互矛盾的结果。这些问题的解决有待明确鉴定具有适当亚细胞结构的钙转运机制。